glucagon vs glp-1 Glucagon-like peptide 1 in health and disease The dual glucose-dependent insulinotropic polypeptide

and (4) anecdotal experiences of the positive psychological impact of GLP-1 RA use

The program ends on December 31, 2027

[DOI] [PMC free article] [PubMed] [Google Scholar] 50.Schwimmer J.B., Newton K.P., Awai H.I., et al

"Finding new and better treatments is critically important to help people live healthier lives." References Nirupam M Srinivasan, Mehdi Farokhnia, Lisa A Farinelli, Anna Ferrulli, Lorenzo Leggio, GLP-1 Therapeutics and Their Emerging Role in Alcohol and Substance Use Disorders: An Endocrinology Primer, Journal of the Endocrine Society , Volume 9, Issue 11, November 2025, bvaf141,

[PubMed] Capehorn MS, Catarig AM, Furberg JK, et al